Douglas Borthwick Selected by Expertise to be Among one of the 2023 Best Family Lawyers in Riverside
SANTA ANA, Calif., Feb. 26, 2024 /PRNewswire/ — Expertise is pleased to announce that Douglas Borthwick, Esq. was recently named by Expertise.com as one of the Best Family Lawyers in Riverside. Expertise is an organization that aims to serve the general public by compiling a list of the best l
Sapiens and DataCrest Forge Partnership to Elevate Underwriting Precision in P&C Sector
The strategic collaboration accelerates operational efficiencies and drives premium growth for P&C insurers ROCHELLE PARK, N.J., Feb. 26, 2024 /PRNewswire/ — Sapiens International Corporation (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance i
Connectbase Launches “The Connected World – Investors Edition”
BOSTON, Feb. 26, 2024 /PRNewswire/ — Connectbase, The Global Ecosystem for Buying and Selling Connectivity, today announced the launch of a new product: The Connected World – Investors Edition. This product gives digital infrastructure investors a platform to partner, monitor, and analyz
Baicells Announces its Fusion RAN Network Platform for Mobile Operators and Service Providers
Highly Flexible and Innovative RAN Solution offers ability to deliver 2G, 4G, and 5G services from single network platform. DALLAS, Feb. 26, 2024 /PRNewswire/ — Baicells Technologies, a global provider of turnkey 4G LTE and 5G NR solutions for operators and the enterprise, has announced the la
METALLA PROVIDES UPDATE ON GOSSELIN & CÔTÉ ROYALTY AND 2024 CATALYSTS
Beedie Capital to increase equity ownership to 9.99% with additional C$1.5 million investment (All dollar amounts are in United States dollars unless otherwise indicated, except for per share amounts) TSXV: MTANYSE AMERICAN: MTA VANCOUVER, BC, Feb. 26, 2024 /PRNewswire/ – Metalla Royalty &
GSK’s RSV vaccine, Arexvy, accepted for review by Health Canada for prevention of RSV disease in adults aged 50-59 at increased risk
Submission supported by positive results of a Phase III study showing immune response and tolerability in adults aged 50-59Adults aged 50 and above with underlying medical conditions are at increased risk for RSV disease1,2,3GSK is the first company to seek regulatory approval to extend RSV vaccinat
Pharmascience Expands its Contract Development and Manufacturing Organization (CDMO) Services With a New Commercial Business Unit
MONTREAL, Feb. 26, 2024 /CNW/ – Last Fall, Pharmascience, the largest Canadian-owned pharmaceutical company, announced a major $120 million sterile injectable manufacturing facility expansion at its Candiac site. Following this important milestone, the company is now proud to announce the expa
IMC Trading Invites Top STEM Students to Compete in Global Trading Challenge
Innovative competition mimics real-life trading on virtual island archipelago, with a $50,000 USD prize pool up for grabs AMSTERDAM, Feb. 26, 2024 /PRNewswire/ — Global market maker IMC today announced the return of its unique market simulation challenge, Prosperity. ‘The world’s
Change in Medivir’s nomination committee before the 2024 AGM
STOCKHOLM, Feb. 26, 2024 /PRNewswire/ — Medivir AB (Nasdaq Stockholm : MVIR) today announces that that the nomination committee before the annual general meeting in May 2024 changes as follows. Anders Hallberg is leaving the nomination committee and HealthInvest Partners has declined new rep
Mobly Secures $2.5 Million Seed Round to Transform Lead Capture and Qualification in B2B
Funding will accelerate mobile software innovation for field marketers to collect leads at any event and deliver them to sales in seconds LEHI, Utah, Feb. 26, 2024 /PRNewswire/ — Mobile software company, Mobly, today announced it raised $2.5 million in seed funding. The company’s financi
